Stefan Ståhl

9.5k citations

156 papers · 7.6k indexed · 2 hit papers · h-index 46

Molecular Biology top 1%
Radiology, Nuclear Medicine and Imaging top 0.2%
Oncology top 2%
Ecology top 2%
Immunology top 5%

Co-authors: Mathias Uhlén Per‐Åke Nygren John Löfblom Thomas Hultman Vladimir Tolmachev Elin Gunneriusson Anna Orlova Fredrik Y. Frejd
Topics: Monoclonal and Polyclonal Antibodies Research (120 papers)Glycosylation and Glycoproteins Research (44 papers)Radiopharmaceutical Chemistry and Applications (28 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Molecular Biology Biotechnology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Journal of Neuroscience
Partner nations: Sweden France United States

In The Last Decade

Stefan Ståhl

155 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support

1989 660 citations Thomas Hultman, Stefan Ståhl et al. Nucleic Acids Research profile →
Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain

1997 513 citations Stefan Ståhl, Mathias Uhlén et al. profile →

Peers

Countries citing papers authored by Stefan Ståhl

Since Specialization

Citations

This map shows the geographic impact of Stefan Ståhl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Ståhl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Ståhl more than expected).

Fields of papers citing papers by Stefan Ståhl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Ståhl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Ståhl. The network helps show where Stefan Ståhl may publish in the future.

Co-authorship network of co-authors of Stefan Ståhl

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Ståhl. A scholar is included among the top collaborators of Stefan Ståhl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Ståhl. Stefan Ståhl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts 2024 ·ACS Pharmacology & Translational Science ·Jie Zhang,Sara S. Rinne,(unknown),(unknown),E. Bjorklund,Ayman Abouzayed,Stefan Ståhl,John Löfblom,Anna Orlova,Torbjörn Gräslund,Anzhelika Vorobyeva	2
2	Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis 2023 ·Journal of Nuclear Medicine ·(unknown),(unknown),Gry Hulsart‐Billström,Bogdan Mitran,Bo Zhang,(unknown),(unknown),Sofie Ingvast,Jonas Persson,Stefan Ståhl,Olle Korsgren,John Löfblom,Fredrik Wermeling,Olof Eriksson	2
3	Engineering of Affibody Molecules 2023 ·Cold Spring Harbor Protocols ·Stefan Ståhl,Hanna Lindberg,(unknown),John Löfblom,(unknown)	3
4	Construction and Validation of a New Naïve Sequestrin Library for Directed Evolution of Binders against Aggregation-Prone Peptides 2023 ·International Journal of Molecular Sciences ·(unknown),Hanna Lindberg,Stefan Ståhl,John Löfblom	1
5	Bacterial Cell Display for Selection of Affibody Molecules 2023 ·Methods in molecular biology ·(unknown),Stefan Ståhl,John Löfblom	2
6	Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules 2022 ·Biomedicines ·Sara S. Rinne,(unknown),(unknown),Ayman Abouzayed,(unknown),Anzhelika Vorobyeva,John Löfblom,Stefan Ståhl,Anna Orlova,Torbjörn Gräslund	5
7	Staphylococcus carnosus: from starter culture to protein engineering platform 2017 ·Applied Microbiology and Biotechnology ·John Löfblom,Ralf Rosenstein,Minh‐Thu Nguyen,Stefan Ståhl,Friedrich Götz	42
8	Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds 2016 ·mAbs ·Magdalena Malm,Fredrik Y. Frejd,Stefan Ståhl,John Löfblom	39
9	¹⁸⁸Re-Z_HER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment 2014 ·Journal of Nuclear Medicine ·Mohamed Altai,Helena Wållberg,Hadis Honarvar,Joanna Strand,Anna Orlova,Zohreh Varasteh,Mattias Sandström,John Löfblom,Erik Larsson,Sven‐Erik Strand,Mark Lubberink,Stefan Ståhl,Vladimir Tolmachev	23
10	HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically ¹¹C-Labeled Sel-Tagged Affibody Molecule 2012 ·Journal of Nuclear Medicine ·Helena Wållberg,(unknown),Qing Cheng,Frank Leigh Lu,(unknown),Erik Samén,Jan-Olov Thorell,Katarina Johansson,(unknown),Maria Hägg Olofsson,Sharon Stone‐Elander,Elias S.J. Arnér,Stefan Ståhl	25
11	Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules 2011 ·Amino Acids ·Mohamed Altai,Helena Wållberg,Anna Orlova,Maria� Rosestedt,Seyed Jalal Hosseinimehr,Vladimir Tolmachev,Stefan Ståhl	19
12	Engineering and characterization of a bispecific HER2 × EGFR‐binding affibody molecule 2009 ·Biotechnology and Applied Biochemistry ·Mikaela Friedman,Sara Lindström,(unknown),Helene Andersson Svahn,Jörgen Carlsson,Hjalmar Brismar,Lars Gedda,Fredrik Y. Frejd,Stefan Ståhl	55
13	Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation 2008 ·Proceedings of the National Academy of Sciences ·Wolfgang Hoyer,Caroline Grönwall,Andreas Jonsson,Stefan Ståhl,Torleif Härd	356
14	Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. 2006 ·PubMed ·Anna Orlova,Fredrik Nilsson,Maria Wikman,Charles Widström,Stefan Ståhl,Jörgen Carlsson,Vladimir Tolmachev	73
15	In Vitro Characterization of a Bivalent Anti-HER-2 Affibody with Potential for Radionuclide-Based Diagnostics 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Ann-Charlott Steffen,Maria Wikman,Vladimir Tolmachev,Gregory P. Adams,Fredrik Nilsson,Stefan Ståhl,Jörgen Carlsson	78
16	Effect of affinity maturation on biodistribution of radioiodinated anti-HER2 Affibody molecules 2005 ·European Journal of Nuclear Medicine and Molecular Imaging ·Anna Orlova,(unknown),Tove Eriksson,Marie Nilsson,(unknown),Vladimir Tolmachev,Stefan Ståhl,Fritjof Nilsson	1
17	Strategies for Gene Fusions 2003 ·Humana Press eBooks ·Stefan Ståhl,Per‐Åke Nygren,Mathias Uhlén	3
18	Characterization of immune responses to experimental polyvalent subunit vaccines assembled in iscoms 1998 ·Molecular Immunology ·Anders Sjölander,Niklas Ahlborg,Stefan Ståhl,Roland Andersson	3
19	Surface display compared to periplasmic expression of a malarial antigen inSalmonella typhimuriumand its implications for immunogenicity 1995 ·FEMS Immunology & Medical Microbiology ·Diana Haddad,Sissela Liljeqvist,Sanjai Kumar,Marianne Hansson,Stefan Ståhl,Hedvig Perlmann,Peter Perlmann,Klavs Berzins	40
20	Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid supportbreakdown → 1989 ·Nucleic Acids Research ·Thomas Hultman,Stefan Ståhl,(unknown),Mathias Uhlén	660

About Stefan Ståhl

Stefan Ståhl is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology, having authored 156 papers that have together received 7.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (120 papers), Glycosylation and Glycoproteins Research (44 papers) and Radiopharmaceutical Chemistry and Applications (28 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.9k citations), Molecular Biology (4.7k citations) and Biotechnology (562 citations). Stefan Ståhl has collaborated with scholars based in Sweden, France and United States. Frequent co-authors include Mathias Uhlén, Per‐Åke Nygren, John Löfblom, Thomas Hultman, Vladimir Tolmachev, Elin Gunneriusson, Anna Orlova, Fredrik Y. Frejd, Caroline Grönwall and Sissela Liljeqvist. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact